The RECIPE study: reducing emergency Caesareans and improving the Primiparous experience: a blinded, prospective, observational study.


Journal

BMC pregnancy and childbirth
ISSN: 1471-2393
Titre abrégé: BMC Pregnancy Childbirth
Pays: England
ID NLM: 100967799

Informations de publication

Date de publication:
29 Jul 2020
Historique:
received: 22 12 2018
accepted: 15 07 2020
entrez: 31 7 2020
pubmed: 31 7 2020
medline: 18 5 2021
Statut: epublish

Résumé

The RECIPE study aims to validate a risk prediction model for intrapartum caesarean delivery which has been developed by our group. The Genesis study was a prospective observational study carried out by the Perinatal Ireland Research Consortium across 7 clinical centres in Ireland between October 2012 and June 2015. Genesis investigated a range of maternal and fetal parameters in a prospective blinded study of 2336 singleton pregnancies between 39 + 0-41 + 0 weeks' gestational age. This resulted in the development of a risk prediction model for Caesarean Delivery in nulliparous women at term. The RECIPE study now proposes to provide external validation of this risk prediction tool. In order to externally validate the model, we aim to include a centre which was not involved in the original study. We propose a trial of risk-assignment for intrapartum caesarean amongst nulliparous women with a singleton pregnancy between 38 + 0 and 40 + 6 weeks' gestational age who are planning a vaginal birth. Results of the risk prediction tool will be concealed from participants and from midwives and doctors providing labour care.. Participants will be invited for an ultrasound scan and delivery details will be collated postnatally. The principal aim of this study is to externally validate the risk prediction model. This prediction model holds the potential to accurately identify nulliparous women who are likely to achieve an uncomplicated vaginal birth and those at high prospect of requiring an unplanned caesarean delivery. Validation of the Genesis prediction model would enable more accurate counselling for women in the antenatal setting regarding their own likelihood of requiring an intrapartum Caesarean section. It would also provide valuable personalised information to women about the anticipated course of their own labour. We believe that this is an issue of national relevance that will impact positively on obstetric practice, and will positively empower women to make considered, personalised choices surrounding labour and delivery.

Sections du résumé

BACKGROUND BACKGROUND
The RECIPE study aims to validate a risk prediction model for intrapartum caesarean delivery which has been developed by our group. The Genesis study was a prospective observational study carried out by the Perinatal Ireland Research Consortium across 7 clinical centres in Ireland between October 2012 and June 2015. Genesis investigated a range of maternal and fetal parameters in a prospective blinded study of 2336 singleton pregnancies between 39 + 0-41 + 0 weeks' gestational age. This resulted in the development of a risk prediction model for Caesarean Delivery in nulliparous women at term. The RECIPE study now proposes to provide external validation of this risk prediction tool.
METHODS METHODS
In order to externally validate the model, we aim to include a centre which was not involved in the original study. We propose a trial of risk-assignment for intrapartum caesarean amongst nulliparous women with a singleton pregnancy between 38 + 0 and 40 + 6 weeks' gestational age who are planning a vaginal birth. Results of the risk prediction tool will be concealed from participants and from midwives and doctors providing labour care.. Participants will be invited for an ultrasound scan and delivery details will be collated postnatally. The principal aim of this study is to externally validate the risk prediction model. This prediction model holds the potential to accurately identify nulliparous women who are likely to achieve an uncomplicated vaginal birth and those at high prospect of requiring an unplanned caesarean delivery.
DISCUSSION CONCLUSIONS
Validation of the Genesis prediction model would enable more accurate counselling for women in the antenatal setting regarding their own likelihood of requiring an intrapartum Caesarean section. It would also provide valuable personalised information to women about the anticipated course of their own labour. We believe that this is an issue of national relevance that will impact positively on obstetric practice, and will positively empower women to make considered, personalised choices surrounding labour and delivery.

Identifiants

pubmed: 32727490
doi: 10.1186/s12884-020-03112-6
pii: 10.1186/s12884-020-03112-6
pmc: PMC7390864
doi:

Types de publication

Journal Article Multicenter Study Observational Study Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

431

Références

Am J Obstet Gynecol. 2016 Jan;214(1):79-90.e36
pubmed: 26070707
Stat Med. 2016 Jan 30;35(2):214-26
pubmed: 26553135
BJOG. 2017 Mar;124(4):631-639
pubmed: 27862837
Stat Med. 2017 Dec 10;36(28):4529-4539
pubmed: 27891652

Auteurs

Niamh C Murphy (NC)

Obstetrics & Gynaecology, Royal College of Surgeons in Ireland, Dublin, Ireland. nmurphy@rcsi.ie.

Naomi Burke (N)

Obstetrics & Gynaecology, Royal College of Surgeons in Ireland, Dublin, Ireland.

Patrick Dicker (P)

Epidemiology & Public Health, Royal College of Surgeons in Ireland, Dublin, Ireland.

Fiona Cody (F)

Obstetrics & Gynaecology, Rotunda Hospital, Dublin, Ireland.

Etaoin Kent (E)

Obstetrics & Gynaecology, Royal College of Surgeons in Ireland, Dublin, Ireland.

Elizabeth C Tully (EC)

Obstetrics & Gynaecology, Royal College of Surgeons in Ireland, Dublin, Ireland.

Fergal D Malone (FD)

Obstetrics & Gynaecology, Royal College of Surgeons in Ireland, Dublin, Ireland.

Fionnuala M Breathnach (FM)

Obstetrics & Gynaecology, Royal College of Surgeons in Ireland, Dublin, Ireland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH